Kenvue Appoints Interim CEO and Launches Strategic Review
24 Jul 2025 4 minute read 0 comments Perfectionist25
Kenvue (KVUE), the maker of Tylenol and Listerine, has appointed board member Kirk Perry as interim CEO, replacing Thibaut Mongon, as part of a strategic review to enhance shareholder value. Kenvue, once part of Johnson & Johnson (JNJ), is likely loo...
